US2015224082A1PendingUtilityA1

Formulation and method to induce a deep state of relaxation

46
Assignee: KELLER RAYMOND MICHAELPriority: May 4, 2011Filed: Apr 24, 2015Published: Aug 13, 2015
Est. expiryMay 4, 2031(~4.8 yrs left)· nominal 20-yr term from priority
Inventors:Raymond M. Keller
A61K 31/197A61M 16/109A23L 33/175A61M 21/02A61K 9/0073A61K 31/4045C07D 209/16A61P 25/00C07D 209/20A61M 2205/36A61K 31/405A23V 2002/00C07C 229/36A23L 33/15A61M 15/06
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A relaxation formulation structured to induce a deep state of relaxation in a person comprises amounts of tryptophan, melatonin, vitamin B3, and vitamin B6. Another relaxation formulation also includes an amount of tyrosine, and yet another formulation includes an amount of vitamin B12. At least one embodiment of a relaxation formula comprises a physiologically effective amount of gamma-aminobutyric acid (“GABA”). A delivery system is provided to facilitate administration of the relaxation formulation to a person. The delivery system may include an edible high carbohydrate matrix, such as a chocolate brownie. Alternatively, the delivery system may comprise an inert vaporizable compound to allow the components of the relaxation formulation to be inhaled directly into the lungs of a person. Other delivery systems include an aqueous sublingual spray and a beverage.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A relaxation formulation dissolved into an inert vaporizable compound to be inhaled directly into a person's lungs and induce a deep state of relaxation in the person, said relaxation formulation comprising:
 an amount of L-tryptophan of about 1 to 5 milligrams per milliliter,   an amount of melatonin of about 1 to 5 milligrams per milliliter, and   an amount of gamma-aminobutyric acid of about 1 to 5 milligrams per milliliter.   
     
     
         2 . The formulation as recited in  claim 1  wherein said amount of L-tryptophan is about 1 milligram per milliliter. 
     
     
         3 . The formulation as recited in  claim 1  wherein said amount of melatonin is about 1 milligram per milliliter. 
     
     
         4 . The formulation as recited in  claim 1  wherein said amount of gamma-aminobutyric acid is about 1 milligram per milliliter. 
     
     
         5 . The formulation as recited in  claim 1  wherein said amount of melatonin is about 1 to 2 milligrams per milliliter. 
     
     
         6 . The formulation as recited in  claim 5  wherein said amount of L-tryptophan is about 1 milligram per milliliter. 
     
     
         7 . The formulation as recited in  claim 5  wherein said amount of gamma-aminobutyric acid is about 1 milligram per milliliter. 
     
     
         8 . The formulation as recited in  claim 6  wherein said amount of gamma-aminobutyric acid is about 1 milligram per milliliter. 
     
     
         9 . A relaxation formulation dissolved into an inert vaporizable compound to be inhaled directly into a person's lungs and induce a deep state of relaxation in the person, said relaxation formulation comprising:
 an amount of L-tryptophan of about 1 milligram per milliliter,   an amount of melatonin of about 1 milligram per milliliter, and   an amount of gamma-aminobutyric acid of about 1 milligram per milliliter.   
     
     
         10 . A method for inducing a deep state of relaxation in a person comprising the step of:
 administering a relaxation formulation to the person by dissolving the relaxation formation into an inert vaporizable compound and vaporizing the inert vaporizable compound via exposure to a heat source for inhalation directly into the lungs of the person, wherein the relaxation formulation comprises a predetermined amount of each of tryptophan, melatonin, and gamma-aminobutyric acid.   
     
     
         11 . The method as recited in  claim 10  wherein the heat source comprises an electronic cigarette. 
     
     
         12 . The method as recited in  claim 10  wherein the predetermined amount of L-tryptophan is about 1 to 5 milligrams per milliliter. 
     
     
         13 . The method as recited in  claim 10  wherein the predetermined amount of melatonin is about 1 to 5 milligrams per milliliter. 
     
     
         14 . The method as recited in  claim 10  wherein the predetermined amount of gamma-aminobutyric acid is about 1 to 5 milligrams per milliliter. 
     
     
         15 . The method as recited in  claim 10  wherein the predetermined amount of L-tryptophan is about 1 milligram per milliliter. 
     
     
         16 . The method as recited in  claim 15  wherein the predetermined amount of melatonin is about 1 to 2 milligrams per milliliter. 
     
     
         17 . The method as recited in  claim 15  wherein the predetermined amount of gamma-aminobutyric acid is about 1 milligram per milliliter. 
     
     
         18 . The method as recited in  claim 16  wherein the predetermined amount of gamma-aminobutyric acid is about 1 milligram per milliliter. 
     
     
         19 . The method as recited in  claim 18  wherein the heat source comprises an electronic cigarette.

Join the waitlist — get patent alerts

Track US2015224082A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.